Norman Atkins, Jr, Jr, PhD, MBA

Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey

  • 3Articles
  • 22.9KReads
  • 2019–2026Active
  • 14Collaborators
  • 32Citations

About

Norman Atkins, Jr, PhD, MBA, is affiliated with Otsuka Pharmaceutical Development & Commercialization, Inc. in Princeton, New Jersey. His publications span from 2019 to 2026 and focus on clinical topics including bipolar disorder, neurodevelopmental conditions, and sleep disorders. His work includes studies on maintenance treatment with aripiprazole in bipolar I disorder, comparative analyses of hypnotics for insomnia, and evaluations of treatment needs in adults with attention-deficit/hyperactivity disorder. He has collaborated frequently with co-authors such as Amica Simmons-Yon and Beverly Romero.

Publications

JCP
Safety and Efficacy of Maintenance Treatment with Aripiprazole Once-Monthly in Black/African American Adults With Bipolar I Disorder
Original Research

Safety and Efficacy of Maintenance Treatment with Aripiprazole Once-Monthly in Black/African American Adults With Bipolar I Disorder

March 9, 2026

The safety and efficacy of AOM 400 were comparable between Black/African American and non-Black/African American patients with bipolar I disorder
, , , et al
JCP
Original Research

Lemborexant NNT, NNH, and LHH for Treatment of Insomnia

June 1, 2021

Many pharmacologic treatment options are available for insomnia. In this study, the clinical utility of the new hypnotic lemborexant is given clinical perspective via the evidence-based medicine tools of...
, , , et al
PCC
Original Research

Patient Perspective on Unmet Needs in ADHD Treatment

June 6, 2019

What do patients consider as unmet needs regarding ADHD treatment? This study examined the impairment experienced in the daily life of adults with ADHD currently treated with pharmacotherapy relative...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe